| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A distinct miRNA expression profile in hepatocellular carcinoma arising in carriers of the I148M PNPLA3 gene variant
|
Donati, B.
|
|
2015
|
47 |
S3 |
p. e231-
1 p.
|
article
|
| 2 |
A novel algorithm based on serum SCCA-IgM determination combined with common clinical data improves prediction of histological NASH
|
Gallotta, A.
|
|
2015
|
47 |
S3 |
p. e226-
1 p.
|
article
|
| 3 |
Cardiovascular risk and inflammation in nonalcoholic fatty liver disease: The upregulation of inflammatory platelet transcripts suggest a role for platelets in the “inflammatory network” of NAFLD
|
Alberelli, M.A.
|
|
2015
|
47 |
S3 |
p. e222-
1 p.
|
article
|
| 4 |
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis
|
Nascimbeni, F.
|
|
2015
|
47 |
S3 |
p. e221-e222
nvt p.
|
article
|
| 5 |
Daily supplementation of cholecalciferol prevents liver steatosis and diabetes by improving insulin sensitivity in an animal model of NAFLD
|
Mazzone, G.
|
|
2015
|
47 |
S3 |
p. e235-
1 p.
|
article
|
| 6 |
Different clinical patterns of hepatocellular carcinoma (HCC) in patients with NAFLD and HCV related chronic liver disease
|
Gianstefani, A.
|
|
2015
|
47 |
S3 |
p. e232-
1 p.
|
article
|
| 7 |
Editorial board
|
|
|
2015
|
47 |
S3 |
p. i-
1 p.
|
article
|
| 8 |
Effect of age and gender in the progression of NAFLD towards NASH in a juvenile mice model
|
Marin, V.
|
|
2015
|
47 |
S3 |
p. e227-
1 p.
|
article
|
| 9 |
Efficacy of Mediterranean diet in a peculiar case of non-alcoholic steatohepatitis and hypobetalipoproteinemia
|
Marrone, G.
|
|
2015
|
47 |
S3 |
p. e233-
1 p.
|
article
|
| 10 |
Epicardial and liver fat, evaluated by ultrasound in general population and in non-alcoholic fatty liver disease (NAFLD) predict cardiovascular damage
|
Pisano, G.
|
|
2015
|
47 |
S3 |
p. e223-
1 p.
|
article
|
| 11 |
Heparanase in NASH: Is it an useful marker of fibrogenesis?
|
Marrone, G.
|
|
2015
|
47 |
S3 |
p. e223-
1 p.
|
article
|
| 12 |
Hepatic insulin resistance in NAFLD: Relationship with markers of atherosclerosis and metabolic syndrome components
|
Privitera, G.
|
|
2015
|
47 |
S3 |
p. e226-e227
nvt p.
|
article
|
| 13 |
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: Incidence, characteristics, risk factors and survival
|
Rinaldi, L.
|
|
2015
|
47 |
S3 |
p. e222-e223
nvt p.
|
article
|
| 14 |
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease
|
Giraudi, P.J.
|
|
2015
|
47 |
S3 |
p. e221-
1 p.
|
article
|
| 15 |
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters
|
Di Pasqua, L.G.
|
|
2015
|
47 |
S3 |
p. e232-
1 p.
|
article
|
| 16 |
Interaction between dietary factors and insulin resistance in the pathogenesis of nonalcoholic steatohepatitis
|
Meroni, M.
|
|
2015
|
47 |
S3 |
p. e230-
1 p.
|
article
|
| 17 |
Involvement of the IDO-1 pathway in experimental NASH
|
Vivoli, E.
|
|
2015
|
47 |
S3 |
p. e234-e235
nvt p.
|
article
|
| 18 |
Liver fat accumulation is associated with circulating PCSK9 levels
|
Dongiovanni, P.
|
|
2015
|
47 |
S3 |
p. e230-
1 p.
|
article
|
| 19 |
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH
|
Berardo, C.
|
|
2015
|
47 |
S3 |
p. e231-
1 p.
|
article
|
| 20 |
NAFLD: The impact of diet and aerobic exercise, alone or in combination with nutraceuticals, on biochemical parameters
|
Carrara, M.
|
|
2015
|
47 |
S3 |
p. e232-e233
nvt p.
|
article
|
| 21 |
Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes
|
Mantovani, A.
|
|
2015
|
47 |
S3 |
p. e229-
1 p.
|
article
|
| 22 |
Pathogenesis of non-alcoholic steatohepatitis in patients with inflammatory bowel disease is different from non-bowel disease subjects
|
Sartini, A.
|
|
2015
|
47 |
S3 |
p. e233-
1 p.
|
article
|
| 23 |
Protective role of soluble receptor of advanced glycation end-products in non-alcoholic fatty liver disease
|
Salomone, F.
|
|
2015
|
47 |
S3 |
p. e234-
1 p.
|
article
|
| 24 |
Role of the receptor tyrosine kinase MER in the development of fibrosis in NAFLD
|
Di Maira, G.
|
|
2015
|
47 |
S3 |
p. e225-
1 p.
|
article
|
| 25 |
Silibinin exerts beneficial effects in experimental and human non-alcoholic steatohepatitis
|
Salomone, F.
|
|
2015
|
47 |
S3 |
p. e234-
1 p.
|
article
|
| 26 |
Silybin as therapeutic approach in an in vitro model of NAFLD
|
Marin, V.
|
|
2015
|
47 |
S3 |
p. e228-
1 p.
|
article
|
| 27 |
Steatosis in patients with HCV chronic liver disease: Baseline results from patients enrolled in the PITER cohort study
|
Weimer, L.E.
|
|
2015
|
47 |
S3 |
p. e224-e225
nvt p.
|
article
|
| 28 |
The independent predictors of NASH and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, ALT and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment
|
Ballestri, S.
|
|
2015
|
47 |
S3 |
p. e229-
1 p.
|
article
|
| 29 |
The presence of white matter lesions is associated with the histological severity of non-alcoholic fatty liver disease
|
Petta, S.
|
|
2015
|
47 |
S3 |
p. e228-
1 p.
|
article
|
| 30 |
Therapeutic approach to NAFLD/NASH: Is Silimarin able to ameliorate liver injury?
|
Marin, V.
|
|
2015
|
47 |
S3 |
p. e227-
1 p.
|
article
|
Journal description